Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial-Reference-Cited by-同舟云学术

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

Published:2002-06 Issue:9323 Volume:359 Page:2053-2058
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Lederman Robert J,Mendelsohn Farrell O,Anderson R David,Saucedo Jorge F,Tenaglia Alan N,Hermiller James B,Hillegass William B,Rocha-Singh Krishna,Moon Thomas E,Whitehouse MJ,Annex Brian H

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Update on some epidemiologic features of intermittent claudication: the Framingham Study;Kannel;J Am Geriatr Soc,1985

2. Medical treatment of peripheral arterial disease and claudication;Hiatt;N Engl J Med,2001

3. Seminars in medicine of the Beth Israel Hospital, Boston: clinical applications of research on angiogenesis;Folkman;N Engl J Med,1995

4. Therapeutic angiogenesis in ischemic limbs;Folkman;Circulation,1998

5. Basic fibroblast growth factor induces angiogenesis in vitro;Montesano;Proc Natl Acad Sci USA,1986

Cited by 458 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable Alginate-Based Hydrogels Encapsulating Engineered Endothelial Extracellular Vesicles for the Treatment of Critical Limb Ischemia;Biomacromolecules;2024-09-12

2. Therapeutic Angiogenesis and Cardiovascular Disease: A Review;Cardiology in Review;2024-05-30

3. Modified EBP‐bFGF targeting endogenous renal extracellular matrix protects against renal ischemia‐reperfusion injury in rats;Journal of Biomedical Materials Research Part A;2024-05-03

4. A biomimetic approach to modulating the sustained release of fibroblast growth factor 2 from fibrin microthread scaffolds;Exploration of BioMat-X;2024-04-23

5. NRP1-expressing monocyte/macrophages promote arteriogenesis in the ischemic limb;2024-02-12